Applying Best Clinical Practices to Patients at High Risk of Respiratory Complications
Conditions: Respiratory Complication; Obstructive Sleep Apnea Intervention: Drug: Sugammadex 100 MG/ML [Bridion] Sponsors: University of California, Los Angeles; Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Research | Respiratory Medicine